Sportsbooks are off to a strong start to the NFL season. Macquarie estimated that the hold rates on NFL games jumped to 16% ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 21.46% ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.71% of ...

Fintel reports that on September 19, 2024, BTIG upgraded their outlook for DoorDash (NasdaqGS:DASH) from Neutral to Buy.

DoorDash (NASDAQ:DASH) gained in early trading on Thursday after BTIG upgraded the online food delivery stock to a Buy rating ...

GE Healthcare Technologies (GEHC) stock was upgraded by BTIG to Buy, due to the company's potential to meet or exceed its H2 ...

BTIG has reaffirmed its positive stance on Airbnb Inc. (NASDAQ: ABNB) with a "Buy" rating and a $55.00 price target. The recommendation follows a group investor meeting held last week with Airbnb ...

BTIG has maintained its Buy rating on J.Jill Inc. (NYSE: JILL) with a steady price target of $44.00. The firm's stance comes as J.Jill reported a second quarter that surpassed expectations ...

In a report released yesterday, Marie Thibault from BTIG reiterated a Hold rating on Embecta Corporation (EMBC – Research Report). The company’s shares closed yesterday at $16.46. Thibault ...

Athira Pharma (ATHA – Research Report) received a Hold rating and price target from BTIG analyst Thomas Shrader yesterday. The company’s shares closed yesterday at $2.83. Shrader covers the ...

BTIG has reaffirmed its Buy rating on Gain Therapeutics (NASDAQ: GANX) with a steady price target of $10.00. The firm's assessment follows Gain's recent announcement regarding its Phase 1 study ...